» PAI-1 Immunodepleted Deficient Human Plasma

RESEARCH DEFICIENT PLASMAS IMMUNODEPLETED DEFICIENT PLASMAS

PAI-1 Immunodepleted Deficient Human Plasma

Fresh Frozen Plasmas

Immunodepleted deficient plasma for PAI-1 assay.

Plasminogen activator inhibitor 1 (PAI-1) immunodepleted human plasma buffered with 20mM HEPES.

Reference	Presentation	Packaging
6-FDPPAI	Bottle	100 mL
6-FDPPAI-10	Kit	10 x 1.0 mL

Price list, safety data sheets and notices are accessible to our registered customers.

Plasminogen activator inhibitor (PAI-1) is a glycoprotein, the main inhibitor of t-PA and u-PA. It plays an important role in controlling excessive fibrinolysis. PAI-1 is mainly synthesized by vascular endothelial cells, as well as by other cells (hepatocyte, SMC, fibroblasts...). It circulates in plasma in 3 forms: an active form bound to vitronectin, a latent free form and an inactive form. By inhibiting t-PA and u-PA, PAI-1 limits plasminogen activation and controls fibrinous thrombus degradation.

- Frozen, immuno-depleted plasmas are certified to have less than 1% for the deficient factor considered, both for the antigenic and functional assay in haemostasis.
This box is intended for research use

- No bovine additives
- No reconstitution error
- No deterioration of plasmas linked to freeze-drying
- Ready to use after thawing (4 min at 37 °C)

- 10 cryotubes x 1 mL of frozen plasma

a2-Antiplasmin Immunodepleted Deficient Human Plasma
ANCIENNE REF Factor IX immuno depleted human deficient plasma
ANCIENNE REF Factor VIII immuno depleted human deficient plasma
ANCIENNE REF Factor XI immuno depleted deficient plasma
ANCIENNE REF Factor XII immuno depleted human deficient plasma
Antithrombin deficient plasma immuno depleted
Antithrombin Immunodepleted Deficient Human Plasma
Antithrombin/Heparin Cofactor II Immunodepleted Deficient Human Plasma
Factor IX immuno depleted deficient plasma
Factor V immuno depleted deficient plasma
Fibrinogen Immunodepleted Deficient Human Plasma
Heparin Cofactor II Immunodepleted Deficient Human Plasma
Kininogen Immunodepleted Deficient Human Plasma
Plasma Factor VII deficient immuno depleted
Plasma Factor VIII deficient chemically depleted
Plasma Factor X deficient immuno depleted
Plasma Factor XI deficient immuno depleted
Plasma Factor XII deficient immuno depleted
Prothrombin deficient plasma immuno depleted

	These kits are manufactured in accordance with the 98/79 EC directive for in vitro diagnostic devices. Only CE marked products can be used for diagnostic applications in Europe.
	These kits are intended for in vitro diagnostic use.
	These kits are for research use only and are not intended to be used for diagnostic procedures.
	Federal Drug Administration, FDA validates diagnostic kits for in vitro diagnostic use in the United States.
	Biological risk products.
	Storage between 2 and 8 ° C.
	Reactive in liquid form.
	Reactive in lyophilized form.
	Reactive in frozen form.
	Stability after opening at 2-8 ° C.
	Products that can be refrozen.
	Stability 12 months after refreezing at -20 ° C.
	Manufacturer.
	Importer.
	Distributor.

RESEARCH DEFICIENT PLASMAS IMMUNODEPLETED DEFICIENT PLASMAS

PAI-1 Immunodepleted Deficient Human Plasma

Fresh Frozen Plasmas

Price list, safety data sheets and notices are accessible to our registered customers.

Cryopep Catalogue
Thrombosis Haemostasis 2023

Cryopep Catalogue
Haemostasis Research 2023

Cryopep DEFICIENT PLASMAS

Product sheet PAI-1 Immunodepleted Deficient Human Plasma

T-TAS® 01 New

You must identify yourself to search for a certificate of analysis

PAI-1 Immunodepleted Deficient Human Plasma

Fresh Frozen Plasmas

Product sheet

Price list, safety data sheets and notices are accessible to our registered customers.